Cargando…

The epithelial polarity regulator LGALS9/galectin-9 induces fatal frustrated autophagy in KRAS mutant colon carcinoma that depends on elevated basal autophagic flux

Oncogenic mutation of KRAS (Kirsten rat sarcoma viral oncogene homolog) in colorectal cancer (CRC) confers resistance to both chemotherapy and EGFR (epidermal growth factor receptor)-targeted therapy. We uncovered that KRAS mutant (KRAS(mut)) CRC is uniquely sensitive to treatment with recombinant L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiersma, Valerie R, de Bruyn, Marco, Wei, Yunwei, van Ginkel, Robert J, Hirashima, Mitsuomi, Niki, Toshiro, Nishi, Nozomu, Zhou, Jin, Pouwels, Simon D, Samplonius, Douwe F, Nijman, Hans W, Eggleton, Paul, Helfrich, Wijnand, Bremer, Edwin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Basic Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590647/ https://www.ncbi.nlm.nih.gov/pubmed/26086204 http://dx.doi.org/10.1080/15548627.2015.1063767

Ejemplares similares

Galectin-9 Activates and Expands Human T-Helper 1 Cells
por: Gooden, Marloes J. M., et al.
Publicado: (2013)

The Glycan-Binding Protein Galectin-9 Has Direct Apoptotic Activity toward Melanoma Cells
por: Wiersma, Valerie R, et al.
Publicado: (2012)

Cell Surface Galectin-9 Expressing Th Cells Regulate Th17 and Foxp3(+) Treg Development by Galectin-9 Secretion
por: Oomizu, Souichi, et al.
Publicado: (2012)

Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction
por: Hendriks, Djoke, et al.
Publicado: (2016)

A new emerging target in cancer immunotherapy: Galectin-9 (LGALS9)
por: Lv, Yan, et al.
Publicado: (2022)

Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies
por: Madireddi, Shravan, et al.
Publicado: (2014)

Galectin-9 gene (LGALS9) polymorphisms are associated with rheumatoid arthritis in Brazilian patients
por: Vilar, Kamila de Melo, et al.
Publicado: (2019)

Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production
por: Horio, Yuko, et al.
Publicado: (2017)

Galectin-9 ameliorates fulminant liver injury
por: Tadokoro, Tomoko, et al.
Publicado: (2017)

Galectin-9 Is a Possible Promoter of Immunopathology in Rheumatoid Arthritis by Activation of Peptidyl Arginine Deiminase 4 (PAD-4) in Granulocytes
por: Wiersma, Valerie R., et al.
Publicado: (2019)

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint
por: Koopmans, Iris, et al.
Publicado: (2018)

A versatile pretargeting approach for tumour-selective delivery and activation of TNF superfamily members
por: He, Yuan, et al.
Publicado: (2017)

Galectin-9 Triggers Neutrophil-Mediated Anticancer Immunity
por: Ustyanovska Avtenyuk, Natasha, et al.
Publicado: (2021)

The Ever-Expanding Immunomodulatory Role of Calreticulin in Cancer Immunity
por: de Bruyn, Marco, et al.
Publicado: (2015)

Cancer Therapy Due to Apoptosis: Galectin-9
por: Fujita, Koji, et al.
Publicado: (2017)

Galectin-9 Enhances Cytokine Secretion, but Suppresses Survival and Degranulation, in Human Mast Cell Line
por: Kojima, Reiji, et al.
Publicado: (2014)

Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9
por: Keryer-Bibens, Cécile, et al.
Publicado: (2006)

Galectin-9 suppresses the tumor growth of colon cancer in vitro and in vivo
por: Morishita, Asahiro, et al.
Publicado: (2021)

Galectin-9 Ameliorates Clinical Severity of MRL/lpr Lupus-Prone Mice by Inducing Plasma Cell Apoptosis Independently of Tim-3
por: Moritoki, Masahiro, et al.
Publicado: (2013)

Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma
por: Holderried, Tobias A. W., et al.
Publicado: (2019)

The increase of plasma galectin-9 in a patient with insulin allergy: a case report
por: Chagan-Yasutan, Haorile, et al.
Publicado: (2010)

Galectin-9/TIM-3 Interaction Regulates Virus-Specific Primary and Memory CD8(+) T Cell Response
por: Sehrawat, Sharvan, et al.
Publicado: (2010)

Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2
por: Nunoue, Tomokazu, et al.
Publicado: (2021)

Intracellular Galectin-9 Controls Dendritic Cell Function by Maintaining Plasma Membrane Rigidity
por: Querol Cano, Laia, et al.
Publicado: (2019)

CD20-selective inhibition of CD47-SIRPα “don't eat me” signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab
por: van Bommel, Peter E., et al.
Publicado: (2017)

A novel monoclonal antibody for detection of galectin-9 in tissue sections: application to human tissues infected by oncogenic viruses
por: Barjon, Clément, et al.
Publicado: (2012)

Human Galectin-9 Is a Potent Mediator of HIV Transcription and Reactivation
por: Abdel-Mohsen, Mohamed, et al.
Publicado: (2016)

Characterization of neutralizing antibodies reacting with the 213-224 amino-acid segment of human galectin-9
por: Lhuillier, Claire, et al.
Publicado: (2018)

Galectin-9 prolongs the survival of septic mice by expanding tim-3-expressing natural killer T cells and PDCA-1(+) CD11c(+) macrophages
por: Kadowaki, Takashi, et al.
Publicado: (2013)

Author Correction: Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2
por: Nunoue, Tomokazu, et al.
Publicado: (2021)

Functional variants regulating LGALS1 (Galectin 1) expression affect human susceptibility to influenza A(H7N9)
por: Chen, Yu, et al.
Publicado: (2015)

Galectin-9 Induces Mitochondria-Mediated Apoptosis of Esophageal Cancer In Vitro and In Vivo in a Xenograft Mouse Model
por: Chiyo, Taiga, et al.
Publicado: (2019)

Targeted delivery of a designed sTRAIL mutant results in superior apoptotic activity towards EGFR-positive tumor cells
por: Bremer, Edwin, et al.
Publicado: (2008)

A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection
por: Mengshol, John A., et al.
Publicado: (2010)

Galectin-9 has non-apoptotic cytotoxic activity toward acute myeloid leukemia independent of cytarabine resistance
por: Choukrani, Ghizlane, et al.
Publicado: (2023)

Correction: A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection
por: Mengshol, John A., et al.
Publicado: (2010)

LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons
por: Burbidge, Kevin, et al.
Publicado: (2021)

Mice lacking galectin-3 (Lgals3) function have decreased home cage movement
por: Chaudoin, Tammy R., et al.
Publicado: (2018)

Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα “don’t eat me” immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-presentation
por: Hendriks, Mark A. J. M., et al.
Publicado: (2020)

Activation of Galectin-3 (LGALS3) Transcription by Injurious Stimuli in the Liver Is Commonly Mediated by BRG1
por: Li, Zilong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_937259olmki8q9nsp0s8i04sdu